Startups
EnPlusOne Bio
Develops enzymatic technology for manufacturing RNA medicines. Its ezRNA platform uses engineered enzymes to synthesize RNA, including chemically modified sequences, to support drug discovery and scalable production of therapeutic oligonucleotides.
Team
Amanda AmesScientist I |
Bob FlynnDirector of Engineering |
Clare MurrayCEO |
Dan AhlstedtCo-founder, COO |
Dominic RainoneScientist – Chemistry |
Ella MeyerLead of RNA Synthesis |
George ChurchCo-founder, Advisor |
Jeannine TongAssociate Scientist I |
Jenn DeFreitasAssociate Scientist I |
 Jim WeissmanBoard Director |
Jonathan RittichierCo-founder, CSO |
Jonathan WattsScientific Advisor |
Julia MooreBoard Director |
Jun YangSenior Scientist |
Lucas HoranManufacturing Associate II |
 Paxton MajorBoard Observer |
Sai NeelagiriResearch Associate |
Steven KasokBoard Chair |
Susie GaucherScientist I |
Victoria DeMeoAssociate Scientist II |
Yuliya DantsuSenior Scientist |